
### [NCIT:C132814](http://purl.obolibrary.org/obo/NCIT_C132814)
**Label:** Pharyngeal Carcinoma by AJCC v8 Stage

**Subclasses:** [NCIT:C133003](http://purl.obolibrary.org/obo/NCIT_C133003) (Hypopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C133006](http://purl.obolibrary.org/obo/NCIT_C133006) (Stage II Hypopharyngeal Carcinoma AJCC v8), [NCIT:C132820](http://purl.obolibrary.org/obo/NCIT_C132820) (Stage IV Nasopharyngeal Carcinoma AJCC v8), [NCIT:C133007](http://purl.obolibrary.org/obo/NCIT_C133007) (Stage III Hypopharyngeal Carcinoma AJCC v8), [NCIT:C133005](http://purl.obolibrary.org/obo/NCIT_C133005) (Stage I Hypopharyngeal Carcinoma AJCC v8), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C6048](http://purl.obolibrary.org/obo/NCIT_C6048) (Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C6036](http://purl.obolibrary.org/obo/NCIT_C6036) (Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C9101](http://purl.obolibrary.org/obo/NCIT_C9101) (Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C9099](http://purl.obolibrary.org/obo/NCIT_C9099) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C132818](http://purl.obolibrary.org/obo/NCIT_C132818) (Stage II Nasopharyngeal Carcinoma AJCC v8), [NCIT:C132819](http://purl.obolibrary.org/obo/NCIT_C132819) (Stage III Nasopharyngeal Carcinoma AJCC v8), [NCIT:C133008](http://purl.obolibrary.org/obo/NCIT_C133008) (Stage IV Hypopharyngeal Carcinoma AJCC v8), [NCIT:C132816](http://purl.obolibrary.org/obo/NCIT_C132816) (Nasopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C132817](http://purl.obolibrary.org/obo/NCIT_C132817) (Stage I Nasopharyngeal Carcinoma AJCC v8), 

**Class expressions from DL-Learner:**

- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40293](http://purl.obolibrary.org/obo/NCIT_C40293) (Bartholin Gland Squamous Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40287](http://purl.obolibrary.org/obo/NCIT_C40287) (Vulvar Warty Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40286](http://purl.obolibrary.org/obo/NCIT_C40286) (Vulvar Basaloid Carcinoma))) 38.93%


